Vectors Research Management’s Bristol-Myers Squibb BMY Stock Holding History

Vectors Research Management’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$788K	Hold	13,000	–	–	0.23%	83
2025 Q4	$701K	Hold	13,000	–	–	0.21%	83
2025 Q3	$586K	Hold	13,000	–	–	0.18%	92
2025 Q2	$602K	Hold	13,000	–	–	0.21%	83
2025 Q1	$793K	Sell	13,000 -247	-2%	-$14.4K	0.28%	74
2024 Q4	$749K	Hold	13,247	–	–	0.26%	80
2024 Q3	$693K	Hold	13,247	–	–	0.21%	90
2024 Q2	$550K	Hold	13,247	–	–	0.17%	92
2024 Q1	$718K	Sell	13,247 -183	-1%	-$9.32K	0.2%	93
2023 Q4	$696K	Sell	13,430 -46	-0.3%	-$2.42K	0.2%	95
2023 Q3	$782K	Sell	13,476 -300	-2%	-$18.4K	0.25%	79
2023 Q2	$881K	Sell	13,776 -245	-2%	-$16.4K	0.25%	78
2023 Q1	$972K	Sell	14,021 -89	-0.6%	-$6.28K	0.25%	78
2022 Q4	$1.01M	Buy	14,110 +46	+0.3%	+$3.47K	0.26%	77
2022 Q3	$1M	Sell	14,064 -1,176	-8%	-$85.3K	0.28%	76
2022 Q2	$1.17M	Buy	15,240 +1,067	+8%	+$81.3K	0.3%	79
2022 Q1	$1.03M	Sell	14,173 -73	-0.5%	-$4.9K	0.23%	85
2021 Q4	$888K	Hold	14,246	–	–	0.19%	93
2021 Q3	$843K	Hold	14,246	–	–	0.2%	92
2021 Q2	$952K	Buy	14,246 +73	+0.5%	+$4.76K	0.24%	87
2021 Q1	$895K	Buy	14,173 +100	+0.7%	+$6.22K	0.25%	82
2020 Q4	$873K	Buy	14,073 +907	+7%	+$55.8K	0.27%	76
2020 Q3	$788K	Sell	13,166 -710	-5%	-$42.7K	0.29%	74
2020 Q2	$816K	Buy	13,876 +410	+3%	+$24.5K	0.32%	65
2020 Q1	$751K	Sell	13,466 -100	-0.7%	-$6.11K	0.36%	62
2019 Q4	$871K	Buy	13,566 +450	+3%	+$25.8K	0.35%	62
2019 Q3	$665K	Sell	13,116 -760	-5%	-$35.7K	0.33%	58
2019 Q2	$629K	Sell	13,876 -15	-0.1%	-$699	0.34%	57
2019 Q1	$663K	Buy	13,891 +13,102	+1,661%	+$653K	0.38%	54
2018 Q4	$41K	Sell	789 -13,121	-94%	-$705K	0.02%	204
2018 Q3	$768K	Buy	+13,910	New	+$825K	0.47%	48

Other funds holding BMY

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Vectors Research Management's BMY Position: Q1 2026 in Review

Vectors Research Management held its Bristol-Myers Squibb (BMY) position steady in Q1 2026 at 13,000 shares worth $788K. The position accounts for 0.23% of the portfolio, ranked #83.

Vectors Research Management first reported a position in BMY in Q3 2018 and has held it in 31 quarters since. The position peaked at $1.17M in Q2 2022. 2,520 funds tracked by Wall St. Rank hold BMY as of Q1 2026.

Vectors Research Management held 13,000 shares of Bristol-Myers Squibb worth $788K as of Q1 2026.
Vectors Research Management left its Bristol-Myers Squibb share count unchanged in Q1 2026.
Bristol-Myers Squibb made up 0.23% of Vectors Research Management's portfolio in Q1 2026, its #83 holding.
Vectors Research Management first reported a position in Bristol-Myers Squibb in Q3 2018 and has held it in 31 quarters since.
Vectors Research Management's Bristol-Myers Squibb position peaked at $1.17M in Q2 2022.
2,520 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2026.

Based on Vectors Research Management's 13F filing for Q1 2026, filed 5 May 2026.